Cargando…

Nanoparticle STING Agonist Reprograms the Bone Marrow to an Antitumor Phenotype and Protects Against Bone Destruction

When breast cancer metastasizes to bone, treatment options are limited. Failure to treat bone metastases is thought to be due to therapy-resistant features of the bone marrow microenvironment. Using a murine model of bone metastatic mammary carcinoma, we demonstrate that systemic delivery of polymer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Florian, David C., Bennett, Natalie E., Odziomek, Mateusz, Baljon, Jessalyn J., Wehbe, Mohamed, Merkel, Alyssa R., Fischer, Melissa A., Savona, Michael R., Rhoades, Julie A., Guelcher, Scott A., Wilson, John T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Association for Cancer Research 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10035525/ https://www.ncbi.nlm.nih.gov/pubmed/36968140 http://dx.doi.org/10.1158/2767-9764.CRC-22-0180

Ejemplares similares

Microporous methacrylated glycol chitosan-montmorillonite nanocomposite hydrogel for bone tissue engineering
por: Cui, Zhong-Kai, et al.
Publicado: (2019)

Principles of computer-controlled linear motion applied to an open-source affordable liquid handler for automated micropipetting
por: Florian, David C., et al.
Publicado: (2020)

Diflunisal‐loaded poly(propylene sulfide) nanoparticles decrease S. aureus‐mediated bone destruction during osteomyelitis
por: Ford, Caleb A., et al.
Publicado: (2020)

Hedgehog and TGFβ signaling converge on Gli2 to control bony invasion and bone destruction in oral squamous cell carcinoma
por: Cannonier, Shellese A., et al.
Publicado: (2016)

Identification of MSA-2: An oral antitumor non-nucleotide STING agonist
por: Liu, Jianhua, et al.
Publicado: (2021)

Overcoming resistance to STING agonist therapy to incite durable protective antitumor immunity
por: Lemos, Henrique, et al.
Publicado: (2020)

3D Bone Morphology Alters Gene Expression, Motility, and Drug Responses in Bone Metastatic Tumor Cells
por: Dadwal, Ushashi C., et al.
Publicado: (2020)

Slit2-Mediated Metabolic Reprogramming in Bone Marrow-Derived Macrophages Enhances Antitumor Immunity
por: Kaul, Kirti, et al.
Publicado: (2021)

STING and TLR7/8 agonists-based nanovaccines for synergistic antitumor immune activation
por: Zhang, Bo-Dou, et al.
Publicado: (2022)

Antitumor effect of anti-vascular therapy with STING agonist depends on the tumor microenvironment context
por: Czapla, Justyna, et al.
Publicado: (2023)

Role of zoledronic acid in oncolytic virotherapy: Promotion of antitumor effect and prevention of bone destruction
por: Yamakawa, Yasuaki, et al.
Publicado: (2017)

Myeloid-derived suppressor cells expand during breast cancer progression and promote tumor-induced bone destruction
por: Danilin, Sabrina, et al.
Publicado: (2012)

Effective delivery of STING agonist using exosomes suppresses tumor growth and enhances antitumor immunity
por: McAndrews, Kathleen M., et al.
Publicado: (2021)

Autophagic reprogramming of bone marrow–derived macrophages
por: Mazher, Mayada, et al.
Publicado: (2022)

Potent STING activation stimulates immunogenic cell death to enhance antitumor immunity in neuroblastoma
por: Wang-Bishop, Lihong, et al.
Publicado: (2020)

STING Agonists as Cancer Therapeutics
por: Amouzegar, Afsaneh, et al.
Publicado: (2021)

Bone destruction by Th17
por: Williams, Ruth
Publicado: (2006)

Imaging the Bone-Immune Cell Interaction in Bone Destruction
por: Hasegawa, Tetsuo, et al.
Publicado: (2019)

Altering adsorbed proteins or cellular gene expression in bone-metastatic cancer cells affects PTHrP and Gli2 without altering cell growth
por: Page, Jonathan M., et al.
Publicado: (2015)

Biphasic α2β1 Integrin Expression in Breast Cancer Metastasis to Bone
por: Moritz, Milene N.O., et al.
Publicado: (2021)

The Microtubule Destabilizer Eribulin Synergizes with STING Agonists to Promote Antitumor Efficacy in Triple-Negative Breast Cancer Models
por: Takahashi-Ruiz, Leila, et al.
Publicado: (2022)

Pediatric Myofibroma of the Palate with Ulceration and Bone Destruction
por: Capo, Joseph A., et al.
Publicado: (2016)

Timing of indomethacin in the control of prostaglandins, osteoclasts and bone destruction produced by VX2 carcinoma in rabbits.
por: Galasko, C. S., et al.
Publicado: (1979)

Redirection to the bone marrow improves T cell persistence and antitumor functions
por: Khan, Anjum B., et al.
Publicado: (2018)

Discovery of Novel STING Inhibitors Based on the Structure of the Mouse STING Agonist DMXAA
por: Chang, Jiajia, et al.
Publicado: (2023)

ExoSTING, an extracellular vesicle loaded with STING agonists, promotes tumor immune surveillance
por: Jang, Su Chul, et al.
Publicado: (2021)

Bad to the bone: B cell acute lymphoblastic leukemia cells mediate bone destruction
por: Rajakumar, Sujeetha A., et al.
Publicado: (2020)

429 Eribulin Synergizes with STING Agonists by Enhancing Type 1 Interferon Expression and Improves Antitumor Efficacy as Combination Treatment
por: Takahashi-Ruiz, Leila, et al.
Publicado: (2023)

STING agonist-loaded, CD47/PD-L1-targeting nanoparticles potentiate antitumor immunity and radiotherapy for glioblastoma
por: Zhang, Peng, et al.
Publicado: (2023)

Does immune destruction drive all forms of bone marrow failure?
por: Dulmovits, Brian M., et al.
Publicado: (2022)

Trial watch: STING agonists in cancer therapy
por: Le Naour, Julie, et al.
Publicado: (2020)

Effects of STING stimulation on macrophages: STING agonists polarize into “classically” or “alternatively” activated macrophages?
por: Ohkuri, Takayuki, et al.
Publicado: (2017)

Metabolic Reprogramming of Mouse Bone Marrow Derived Macrophages Following Erythrophagocytosis
por: Catala, Alexis, et al.
Publicado: (2020)

Bone morphogenetic proteins in destructive and remodeling arthritis
por: Lories, Rik JU, et al.
Publicado: (2007)

Regulation of RANKL signaling in arthritic bone destruction
por: Takayanagi, H
Publicado: (2003)

Benign Orbital Tumors with Bone Destruction in Children
por: Yan, Jianhua, et al.
Publicado: (2012)

Cytokine-Mediated Bone Destruction in Rheumatoid Arthritis
por: Jung, Seung Min, et al.
Publicado: (2014)

Smad-dependent mechanisms of inflammatory bone destruction
por: Fennen, Michelle, et al.
Publicado: (2016)

The roles of osteocytes in alveolar bone destruction in periodontitis
por: Huang, Xiaofei, et al.
Publicado: (2020)

The unresolved role of systemic factors in bone metastasis
por: Ubellacker, Jessalyn M., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_4ei8b22ngt1mvcgv1sb8kvltf7